louisakewell, Author at European Medical Journal - Page 59 of 153

Introducing EMJ Nephrology 4.1

United Kingdom, July 5, 2016: Welcome to the 2016 edition of EMJ Nephrology, which provides extensive coverage of research and developments across the…

Anti-Interleukin-1 Alpha Antibody MABp1 Improves Outcomes Significantly over Placebo

Barcelona-Lugano, July 02, 2016 – A novel anti-interleukin 1-alpha antibody has shown a significant impact on symptoms, and a high level of safety and…

Introducing EMJ Interventional Cardiology 4.1

United Kingdom, June 30, 2016: Welcome to the 2016 edition of EMJ Interventional Cardiology, an assortment of the latest news, research, and opinions…

Regorafenib Shows Significant Survival Gains in Refractory Liver Cancer

Barcelona-Lugano, June 30, 2016 – Oral multikinase inhibitor regorafenib achieves significantly improved survival rates compared to placebo in patients…

Chemoradiotherapy after Surgery for Gastric Cancer Shows Similar Outcomes to Post-Operative Chemotherapy

Barcelona-Lugano, June 30, 2016 – Post-operative treatment intensification with chemoradiotherapy does not achieve better outcomes when compared to…

Anti-PD-L1 Immunotherapy Shows Response in Microsatellite-Stable Metastatic Colorectal Cancer in Combination with MEK Inhibition

June 29, 2016 – Anti-PD-L1 immunotherapy may achieve a response in patients with microsatellite-stable metastatic colorectal cancer if combined with…

IBD Drug Availability Putting Children at Risk of Lifelong Health Complications

June 21, 2016 – To halt the health risks for children and improve outcomes in the future, IBD experts across Europe are calling for an urgent increase in…

Richard Wolf Presents Its Profile at the 24th International Congress of the E.A.E.S in Amsterdam

June 16, 2016 – Particularly in contemporary medicine, the importance of efficient processes is steadily increasing on account of the rising pressure…

iVascular Completes Recruitment of Patients for Its ANCHOR Clinical Trial of the Sirolimus Eluting Stent ANGIOLITE

May 19, 2016 – Coordinated by PI Dr. Josep Rodés-Cabau from Quebec Heart and Lung Institute, the objective of ANCHOR clinical trial is to perform a…

iVascular Receives CE Mark Approval for LUMINOR 18 Drug Eluting Balloon

May 16, 2016 – LUMINOR 18, which is 0.018 Guide Wire compatible, is added to the existing LUMINOR range (Luminor14 and Luminor35), to offer the only…